In last trading session, Cano Health Inc. (NYSE:CANO) saw 14.19 million shares changing hands with its beta currently measuring 0. Company’s recent per share price level of $1.52 trading at $0.02 or 1.33% at ring of the bell on the day assigns it a market valuation of $838.20M. That closing price of CANO’s stock is at a discount of -565.79% from its 52-week high price of $10.12 and is indicating a premium of 2.63% from its 52-week low price of $1.48. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 17.69 million shares which gives us an average trading volume of 10.69 million if we extend that period to 3-months.
For Cano Health Inc. (CANO), analysts’ consensus is at an average recommendation of an Overweight while assigning it a mean rating of 2.30. Splitting up the data highlights that, out of 9 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 4 suggested the stock as a Hold whereas 5 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -$0.05 in the current quarter.
Cano Health Inc. (NYSE:CANO) trade information
Upright in the green during last session for gaining 1.33%, in the last five days CANO remained trading in the red while hitting it’s week-highest on Thursday, 11/17/22 when the stock touched $1.52 price level, adding 22.05% to its value on the day. Cano Health Inc.’s shares saw a change of -82.94% in year-to-date performance and have moved -19.15% in past 5-day. Cano Health Inc. (NYSE:CANO) showed a performance of -63.55% in past 30-days. Number of shares sold short was 23.97 million shares which calculate 3.14 days to cover the short interests.
Cano Health Inc. (CANO) estimates and forecasts
Statistics highlight that Cano Health Inc. is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -73.43% of value to its shares in past 6 months, showing an annual growth rate of 29.03% while that of industry is 3.70. Apart from that, the company came raising its revenue forecast for fiscal year 2022. This year revenue growth is estimated to rise 77.10% from the last financial year’s standing.
9 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of $717.93 million for the same. And 9 analysts are in estimates of company making revenue of $744.82 million in the next quarter that will end on Dec 2022.
Cano Health Inc. is more likely to be releasing its next quarterly report on November 09 and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
Cano Health Inc. (NYSE:CANO)’s Major holders
Insiders are in possession of 31.95% of company’s total shares while institution are holding 72.22 percent of that, with stock having share float percentage of 106.13%. Investors also watch the number of corporate investors in a company very closely, which is 72.22% institutions for Cano Health Inc. that are currently holding shares of the company. FMR, LLC is the top institutional holder at CANO for having 31.16 million shares of worth $136.49 million. And as of Jun 29, 2022, it was holding 13.44% of the company’s outstanding shares.
The second largest institutional holder is JP Morgan Chase & Company, which was holding about 16.16 million shares on Jun 29, 2022. The number of shares represents firm’s hold over 6.97% of outstanding shares, having a total worth of $70.78 million.
On the other hand, Fidelity Advisor Growth Opportunities Fund and Fidelity Advisor Health Care Fund are the top two Mutual Funds which own company’s shares. As of Jun 29, 2022, the former fund manager was holding 6.72 million shares of worth $29.43 million or 2.90% of the total outstanding shares. The later fund manager was in possession of 6.0 million shares on Aug 30, 2022, making its stake of worth around $37.02 million in the company or a holder of 2.59% of company’s stock.